<p>Greenup Street Wealth Management LLC 在第三季度购买了 Medtronic PLC (NYSE:MDT - 免费报告) 的新股份，根据其最近向证券交易委员会 (SEC) 提交的 13F 表格。该机构投资者购买了 13,709 股这家医疗技术公司的股票，价值约为 1,306,000 美元。</p>
<ul>
<li>Medtronic 股票找到了立足点——现在正在获得动能</li>
</ul>
<p>其他对冲基金最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在 Medtronic 的股份增加了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，此前在上个季度又购买了 37,265 股。CreativeOne Wealth LLC 在第一季度将其在 Medtronic 的持仓提高了 13.1%。CreativeOne Wealth LLC 现在拥有 14,110 股这家医疗技术公司的股票，价值 1,268,000 美元，此前在上个季度又收购了 1,631 股。Trexquant Investment LP 在第一季度获得了 Medtronic 的新股份，价值 3,006,000 美元。WPG Advisers LLC 在第一季度获得了 Medtronic 的新股份，价值 96,000 美元。最后，GKV Capital Management Co. Inc. 在第一季度购买了 Medtronic 的新头寸，价值约 178,000 美元。目前，82.06% 的股票由机构投资者持有。</p>
<h2>Medtronic 股价下跌 0.8%</h2>
<p>MDT 股票周五开盘价为 96.52 美元。Medtronic PLC 的 12 个月低点为 79.29 美元，12 个月高点为 106.33 美元。该公司的市值为 1,237.4 亿美元，市盈率为 26.02，市盈增长比率为 2.56，贝塔值为 0.71。该公司的 50 日移动平均价格为 97.54 美元，200 日移动平均价格为 93.72 美元。该公司的速动比率为 1.80，流动比率为 2.42，债务股本比率为 0.57。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p>Medtronic (NYSE:MDT - 获取免费报告) 最近在 11 月 18 日星期二发布了其财报。这家医疗技术公司报告本季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出 0.05 美元。该公司本季度的收入为 89.6 亿美元，而市场共识预期为 88.6 亿美元。Medtronic 的股本回报率为 14.86%，净利润率为 13.71%。该公司本季度的收入同比增长 6.6%。在去年同期，该公司每股收益为 1.26 美元。Medtronic 已将其 2026 财年的指引设定为每股收益 5.620-5.660。整体来看，分析师预测 Medtronic PLC 本年度每股收益为 5.46。</p>
<h2>Medtronic 宣布分红</h2>
<p>该公司最近还披露了一项季度分红，将于 1 月 16 日星期五支付。12 月 26 日的股东将获得每股 0.71 美元的分红。除息日为 12 月 26 日。这代表着每年 2.84 美元的分红和 2.9% 的收益率。Medtronic 的分红支付比率 (DPR) 目前为 76.55%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>Medtronic：收入投资者的机会变得更好</li>
</ul>
<p>一些券商最近对 MDT 发布了报告。大和资本市场将 Medtronic 的目标价格从 104.00 美元上调至 117.00 美元，并在 11 月 25 日的报告中给予该公司 “买入” 评级。罗伯特·W·贝尔德在 12 月 16 日的研究报告中设定了 Medtronic 的目标价格为 103.00 美元。花旗集团在 10 月 7 日的研究报告中将 Medtronic 的目标价格从 101.00 美元上调至 112.00 美元，并给予该公司 “买入” 评级。韦斯评级在 12 月 15 日的研究报告中重申了对 Medtronic 股票的 “买入 (b)” 评级。最后，摩根士丹利在 11 月 19 日的报告中将 Medtronic 的目标价格从 107.00 美元上调至 117.00 美元，并给予该股票 “超配” 评级。一位研究分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位给予了持有评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 109.94 美元。</p>
<p><strong>查看我们对 Medtronic 的最新股票分析</strong></p>
<h2>Medtronic 公司简介</h2>
<p>(免费报告)</p>
<p>Medtronic plc 是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司总部位于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
<p>Medtronic 的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Medtronic 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将起飞</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄然抛售股票——原因在这里</li>
</ul>
<p><strong>想看看其他对冲基金持有的 MDT 吗？</strong> 访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>Greenup Street Wealth Management LLC 最近在其最新的 SEC 文件中披露，已收购 13,709 股美敦力（Medtronic PLC），价值约为 1,306,000 美元。美敦力是一家全球医疗技术公司，近期多家机构投资者调整了其持股比例。该公司的股票目前交易价格为 96.52 美元，市值为 1,237.4 亿美元。美敦力最近报告的季度每股收益为 1.36 美元，超出预期，并宣布季度股息为每股 0.71 美元。分析师对该股票给予 “适度买入” 的评级，目标价格为 109.94 美元</p>

<p>Greenup Street Wealth Management LLC purchased a new stake in shares of Medtronic PLC (NYSE:MDT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,709 shares of the medical technology company's stock, valued at approximately $1,306,000.</p>
<div class="lb-trans"><p>Greenup Street Wealth Management LLC 在第三季度购买了 Medtronic PLC (NYSE:MDT - 免费报告) 的新股份，根据其最近向证券交易委员会 (SEC) 提交的 13F 表格。该机构投资者购买了 13,709 股这家医疗技术公司的股票，价值约为 1,306,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>Medtronic 股票找到了立足点——现在正在获得动能</li>
</ul>
</div><p>Other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC grew its stake in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock valued at $3,194,000 after buying an additional 37,265 shares in the last quarter. CreativeOne Wealth LLC raised its position in Medtronic by 13.1% during the first quarter. CreativeOne Wealth LLC now owns 14,110 shares of the medical technology company's stock worth $1,268,000 after acquiring an additional 1,631 shares in the last quarter. Trexquant Investment LP acquired a new stake in Medtronic in the first quarter valued at $3,006,000. WPG Advisers LLC acquired a new stake in Medtronic in the first quarter valued at $96,000. Finally, GKV Capital Management Co. Inc. bought a new position in shares of Medtronic in the 1st quarter valued at about $178,000. 82.06% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在 Medtronic 的股份增加了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股这家医疗技术公司的股票，价值 3,194,000 美元，此前在上个季度又购买了 37,265 股。CreativeOne Wealth LLC 在第一季度将其在 Medtronic 的持仓提高了 13.1%。CreativeOne Wealth LLC 现在拥有 14,110 股这家医疗技术公司的股票，价值 1,268,000 美元，此前在上个季度又收购了 1,631 股。Trexquant Investment LP 在第一季度获得了 Medtronic 的新股份，价值 3,006,000 美元。WPG Advisers LLC 在第一季度获得了 Medtronic 的新股份，价值 96,000 美元。最后，GKV Capital Management Co. Inc. 在第一季度购买了 Medtronic 的新头寸，价值约 178,000 美元。目前，82.06% 的股票由机构投资者持有。</p>
</div><h2>Medtronic Trading Down 0.8%</h2>
<div class="lb-trans"><h2>Medtronic 股价下跌 0.8%</h2>
</div><p>Shares of MDT stock opened at $96.52 on Friday. Medtronic PLC has a 12-month low of $79.29 and a 12-month high of $106.33. The company has a market capitalization of $123.74 billion, a PE ratio of 26.02, a price-to-earnings-growth ratio of 2.56 and a beta of 0.71. The firm has a 50 day moving average price of $97.54 and a two-hundred day moving average price of $93.72. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57.</p>
<div class="lb-trans"><p>MDT 股票周五开盘价为 96.52 美元。Medtronic PLC 的 12 个月低点为 79.29 美元，12 个月高点为 106.33 美元。该公司的市值为 1,237.4 亿美元，市盈率为 26.02，市盈增长比率为 2.56，贝塔值为 0.71。该公司的 50 日移动平均价格为 97.54 美元，200 日移动平均价格为 93.72 美元。该公司的速动比率为 1.80，流动比率为 2.42，债务股本比率为 0.57。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating the consensus estimate of $1.31 by $0.05. The company had revenue of $8.96 billion for the quarter, compared to the consensus estimate of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.The firm's revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.26 earnings per share. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, analysts predict that Medtronic PLC will post 5.46 earnings per share for the current year.</p>
<div class="lb-trans"><p>Medtronic (NYSE:MDT - 获取免费报告) 最近在 11 月 18 日星期二发布了其财报。这家医疗技术公司报告本季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出 0.05 美元。该公司本季度的收入为 89.6 亿美元，而市场共识预期为 88.6 亿美元。Medtronic 的股本回报率为 14.86%，净利润率为 13.71%。该公司本季度的收入同比增长 6.6%。在去年同期，该公司每股收益为 1.26 美元。Medtronic 已将其 2026 财年的指引设定为每股收益 5.620-5.660。整体来看，分析师预测 Medtronic PLC 本年度每股收益为 5.46。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>Medtronic 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Shareholders of record on Friday, December 26th will be given a dividend of $0.71 per share. The ex-dividend date is Friday, December 26th. This represents a $2.84 annualized dividend and a yield of 2.9%. Medtronic's dividend payout ratio (DPR) is presently 76.55%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 1 月 16 日星期五支付。12 月 26 日的股东将获得每股 0.71 美元的分红。除息日为 12 月 26 日。这代表着每年 2.84 美元的分红和 2.9% 的收益率。Medtronic 的分红支付比率 (DPR) 目前为 76.55%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>Medtronic：收入投资者的机会变得更好</li>
</ul>
</div><p>A number of brokerages have recently issued reports on MDT. Daiwa Capital Markets upped their target price on shares of Medtronic from $104.00 to $117.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday, November 25th. Robert W. Baird set a $103.00 price target on Medtronic in a research report on Tuesday, December 16th. Citigroup raised their price objective on Medtronic from $101.00 to $112.00 and gave the company a &#34;buy&#34; rating in a research report on Tuesday, October 7th. Weiss Ratings reiterated a &#34;buy (b)&#34; rating on shares of Medtronic in a research note on Monday, December 15th. Finally, Morgan Stanley boosted their target price on Medtronic from $107.00 to $117.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $109.94.</p>
<div class="lb-trans"><p>一些券商最近对 MDT 发布了报告。大和资本市场将 Medtronic 的目标价格从 104.00 美元上调至 117.00 美元，并在 11 月 25 日的报告中给予该公司 “买入” 评级。罗伯特·W·贝尔德在 12 月 16 日的研究报告中设定了 Medtronic 的目标价格为 103.00 美元。花旗集团在 10 月 7 日的研究报告中将 Medtronic 的目标价格从 101.00 美元上调至 112.00 美元，并给予该公司 “买入” 评级。韦斯评级在 12 月 15 日的研究报告中重申了对 Medtronic 股票的 “买入 (b)” 评级。最后，摩根士丹利在 11 月 19 日的报告中将 Medtronic 的目标价格从 107.00 美元上调至 117.00 美元，并给予该股票 “超配” 评级。一位研究分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位给予了持有评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 109.94 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Medtronic</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Medtronic 的最新股票分析</strong></p>
</div><h2>Medtronic Profile</h2>
<div class="lb-trans"><h2>Medtronic 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.</p>
<div class="lb-trans"><p>Medtronic plc 是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司总部位于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
</div><p>Medtronic's offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).</p>
<div class="lb-trans"><p>Medtronic 的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Medtronic 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将起飞</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄然抛售股票——原因在这里</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 MDT 吗？</strong> 访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Greenup Street Wealth Management LLC 购买了美敦力公司（Medtronic PLC）的新股份 $MDT